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ABSTRACT
Hexokinase 2 is an essential factor for signalling
repression through the Saccharomyces cerevisiae
high-glucose sensing pathway. The main regulatory
mechanism that controls the HXK2 gene expression
in yeast is mediated by the Rgt1 and Med8 transcrip-
tion factors, which repress HXK2 expression in low-
glucosecontainingmedia.Inthisstudy,weshowthat
therepressionactivityofRgt1isregulatedbySnf1and
Tpk3 protein kinases. Binding of Rgt1 to the HXK2
promoter requires Rgt1 phosphorylation by Snf1 or
by an Snf1-dependent protein kinase. Conversely,
Rgt1 hyperphosphorylation by the Tpk3 or by a
Tpk3-dependent protein kinase dissociates Rgt1
from the repressor complex. Two-hybrid and chro-
matin immunoprecipitation experiments indicate
that an Snf1-dependent interaction between Rgt1
and Med8 in the repressor complex is also essential
for Rgt1 repression. The repression of HXK2 trans-
cription by Rgt1 likely occurs through the formation
of a DNA loop in the HXK2 locus, spanning the
promoter and coding regions. These results suggest
that a novel silent-chromatin loop is responsible for
Rgt1-dependent transcriptional regulation of the
HXK2 gene.
INTRODUCTION
The Saccharomyces cerevisiae glucose signalling pathway is
controlled by a series of transcription factors and auxiliary
proteins (1–3). Among them, hexokinase 2 (Hxk2) is an
important repressor in this pathway. Beyond its classic
metabolic role in initiating glucose metabolism, Hxk2 plays
an important rolein controlling the expression of several genes
(4,5). The HXK2 gene is highly expressed during growth in
high-glucose and is sparsely expressed in low-glucose media
(6). However, little is known about the molecular mechanisms
that control the pattern of Hxk2 expression. In this study, we
investigated whether Rgt1 regulates HXK2 gene expression
during glucose metabolism under high- and low-glucose
growth condition.
Recently, Rgt1 and Med8 have been identiﬁed as two essen-
tialfactorsinvolved intherepressionofthe HXK2geneinlow-
glucose medium (7). The Med8 protein binds constitutively to
the downstream regulatory sequence (DRS) of the HXK2 gene
(7–9). Rgt1 binds to the RGT1 element of the HXK2 promoter
in a carbon source-dependent manner (7). Additionally, the
phosphorylation state of Rgt1 has been shown to be important
during transcriptional regulation of HXT1 (10,11). Therefore,
we postulated that glucose may shift the transcriptional activ-
ity of Rgt1 towards HXK2 expression by inducing changes in
the phosphorylation state of the Rgt1 protein.
It is known that in S.cerevisiae, the cAMP-dependent pro-
tein kinase (PKA) is activated by extracellular glucose and
inactivated during glucose deprivation (12). Structurally, the
PKA holoenzyme is a heterotetramer composed of two regu-
latory subunits (Bcy1) and two catalytic subunits of three
possible isoforms (Tpk1, Tpk2, Tpk3). These three catalytic
subunits of PKA can have redundant functions in processes
such as glycogen storage. However, these catalytic isoforms
are not redundant in all cases. For example, Tpk2 is respons-
ible for processes such as pseudohyphal growth, regulation of
genes involved in trehalose degradation and iron uptake (13–
15).Tpk1isrequiredforderepressionofbranched chainamino
acid biosynthesis (14) and Tpk3 is speciﬁcally involved in the
regulation of mitochondrial enzymatic content during growth
(16). The subcellular localization of PKA is regulated by gluc-
ose. Indeed PKA holoenzymes in glucose-grown cells are
localized to the nucleus (17). Since Rgt1 is always located
in the nucleus (18), both PKA and Rgt1 localize to the same
subcellular compartment during high glucose growth condi-
tions. To elucidate the effects of PKA on Rgt1 during high
glucose growth, we investigated each Tpk subunit in this pro-
cess. Here, we show that Tpk3 is responsible for Rgt1 hyper-
phosphorylation during Rgt1 releasefrom the HXK2 promoter.
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Rgt1 to repress HXT1 transcription (10), we postulated that the
absence of Rgt1 phosphorylation may affect HXK2 repression.
In order to elucidate this mechanism, we investigated the
effect of Snf1 kinase activity on Rgt1-dependent repression
of HXK2. The subcellular distribution of Snf1 is also affected
by glucose levels. However, unlike PKA, Snf1 kinase is
directed to the nucleus in low glucose conditions in a
Gal83-dependent manner (19,20). Therefore, both Snf1 and
Rgt1 are located in the same subcellular compartment during
low-glucose growth conditions. In this study, we show that the
yeast protein kinase Snf1 is involved in the modiﬁcation of
Rgt1 required for HXK2 gene repression.
Finally, given previous data (18,21), and data derived from
our current in vivo studies, we propose a model to explain how
low-glucose levels can repress the HXK2 gene expression in
yeast cells.
MATERIALS AND METHODS
Yeast strains and growth media
The S.cerevisiae strains used in these experiments are listed in
Table 1 and are isogenic to the wild-type strain W303-1A,
DBY1315 or BY4742. The rgt1D strain was obtained by trans-
formation with an rgt1::LEU2 allele, which was produced by
PCR using oligonucleotides complementary to RGT1 and
LEU2 contained in pUG73 (26). The FMY152-t3 and
FMY152-s1 strains were obtained by transformation of the
FMY152 strain, respectively, with a tpk3::kanMX4 or
snf1::kanMX4 alleles, which were obtained by PCR using
oligonucleotides complementary to TPK3 or SNF1 and
genomic DNA from the Y15016 or Y14311 strains. Yeast
two-hybrid and co-precipitation experiments employed strains
Y187 (MATa ura3-52 his3-200 ade2-101 trp1-901 leu2-3,112
gal4D gal80D URA3::GAL1UAS-GAL1TATA-lacZ), Y187-Dsnf1
and Y187-Dtpk3. The strains Y187-Dsnf1 and Y187-Dtpk3
were obtained by transformation of the Y187 strain, respect-
ively, with an snf1::kanMX4 or tpk3::kanMX4 allele.
Yeast cells were grown in the following media: YEPD
(4% glucose, 2% peptone and 1% yeast extract; high-glucose
medium), YEPE (0.05%glucose,3%ethanol, 2%peptoneand
1% yeast extract; low-glucose medium) and synthetic media
containing the appropriate carbon source and lacking appro-
priate supplements to maintain selection for plasmids [4%
glucose, (SD); or 0.05% glucose and 3% ethanol, (SE); and
0.67% yeast nitrogen base without amino acids]. Amino acids
and other growth requirements were added at a ﬁnal concen-
tration of 20–150 mg/ml. The solid media contained 2% agar in
addition to the components described above.
General DNA techniques
Restriction enzymes and T4 DNA ligase were from Roche;
radioactively labelled isotopes were from Amersham
International. Routine DNA manipulations were essentially
performed as described previously (27).
Construction of plasmid DNAs
Rgt1 and Med8 fused to the hemaglutinin epitope (HA-Rgt1)
were expressed in yeast from the ADH1 promoter in the
plasmid pWS93 (28). The RGT1 insert was synthesized by
PCR using genomic DNA as a template with the primer pair
OL1+OL2 (OL1: 50-AAGGATCCATGAACGAGCTGAA-
CACTGT-30 and OL2: 50-ATG GATCCTCAAT ACCAGCC-
TAACTCGG-30). Plasmid pWS93/RGT1 carried a 3512 bp
BamHI fragment with the complete coding region of the RGT1
gene in pWS93. HA-Rgt1 was functional as it restores, in low-
glucose media, HXK2 repression in an rgt1D strain. Plasmid
pWS93/MED8 carried a 669 bp BamHI–SalI fragment with
the complete coding region of the MED8 gene in pWS93.
DNA sequencing veriﬁed these PCR-generated constructs.
The HXK2 reporter plasmid YIp357/HXK2+404 was cons-
tructed by placing sequences from  838 to +404 bp relative to
the HXK2 translation start codon, upstream of a lacZ reporter
gene on the integrative yeast vector YIp357 (29). Plasmid
YIp357 is a yeast–Escherichia coli shuttle vector suitable
for use as integrative vector with an URA3 yeast selectable
marker (30).
Plasmid pGEX/RGT1 was constructed by subcloning a
BamHI fragment, with the complete coding region of the
RGT1 gene, from plasmid pWS93/RGT1 in frame into
pGEX-4T (Amersham Biosciences).
Plasmid pGBKT7/RGT1 carried the 3512 bp BamHI
fragment from the pWS93/RGT1 plasmid, with the complete
coding region of the RGT1 gene, in pGBKT7 (Clontech).
Plasmid pGADT7/MED8 carried a 669 bp EcoRI–BamHI
fragment with the complete coding region of the MED8
gene in pGADT7 (Clontech). The MED8 insert was synthe-
sized by PCR using genomic DNA as the template with the
primer pairs OL3+OL4 (OL3, 50-GCGGAATTCATGTCA-
CAATCTACTGCATC-30; OL4, 50-AAGGATCCGCAT-
TACTAGATGATGTTGA-30). Plasmid pACT2/HXK2-485
carried a 1455 bp NcoI/BamHI fragment with the complete
Table 1. Yeast strains used in this study
Strain Genotype References
W303-1A MATa ade2-1 his3-11,15
leu2 -3,112 trp 1-1 ura 3-1
can1-100 TPK1 TPK2 TPK3
(22)
DLY1901 Isogenic to W303-1A, except
forrgt1::LEU2
This work
MB23 Isogenic to W303-1A, except
for tpk2::HIS3 tpk3::URA3
(23)
MB13 Isogenic to W303-1A, except
for tpk1:: LEU2 tpk3::URA3
(23)
MB12 Isogenic to W303-1A, except
for tpk1:: LEU2 tpk2::HIS3
(23)
DBY1315 MATa ura3 -52 leu2-3,2-112
lys2-801 gal2
(24)
FMY152 Isogenic to DBY1315, except
with HXK2p::lacZ
(25)
FMY152-t3 Isogenic to FMY152, except
for tpk3::kanMX4
This work
FMY152-s1 Isogenic to FMY152, except
for snf1::kanMX4
This work
BY4742 MATa; his3D1 leu2 D0 lys2D0
ura3D0
Euroscarf
Y15016 Isogenic to BY4742, except
for tpk3::kanMX4
Euroscarf
Y13967 Isogenic to BY4742, except
for reg1::kanMX4
Euroscarf
Y14311 Isogenic to BY4742, except
for snf1::kanMX4
Euroscarf
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insert was synthesized by PCR using plasmid pSP73/HXK2
(32) as the template with the primer pairs OL5+OL6 (OL5,
50-TACCATGGTTCATTTAGGTCCAAAAA-30; OL6, 50-
ATGGATCCAGCACCGA TGATACCAAC-30). To make
plasmid pGADT7/HXK2-416 a 1245 bp EcoRI–PstI fragment,
obtained from pGADT7/HXK2, and carrying a 213 bp
deletion in the 30 end of HXK2 DNA was ﬁrst subcloned
into the EcoRI and PstI sites of pUK21 and then isolated as
an EcoRI–BamHI fragment and ligated into the EcoRI and
BamHI sites of pGADT7 (Clontech). To make plasmid
pGADT7/HXK2-136 a 408 bp EcoRI–HindIII fragment,
obtained from pGADT7/HXK2, and carrying a 1050 bp
deletion in the 30 end of HXK2 DNA was ﬁrst subcloned
into the EcoRI and HindIII sites of pUK21 and then isolated
as an EcoRI–BamHI fragment and ligated into the EcoRI and
BamHI sites of pGADT7. To make plasmid pGADT7/HXK2-
87 a 261 bp EcoRI–Asp718 fragment, obtained from
pGADT7/HXK2, and carrying a 1197 bp deletion in the 30
end of HXK2 DNA was ﬁrst subcloned into the EcoRI and
Asp718 sites of pSP73 and then isolated as an EcoRI–BamHI
fragment and ligated into the EcoRI and BamHI sites of
pGADT7.
Preparation of crude and nuclear protein extracts
Yeast protein extracts were prepared as follows: yeasts were
grown in 10–20 ml of high or low-glucose medium at 28 Ct o
an optical density at 600 nm of 1.0. Cells were collected,
washed twice with 1 ml of 1 M sorbitol and suspended in
100 ml of 50 mM Tris–HCl (pH 7.5) buffer containing
0.2 mM EDTA, 0.5 mM DTT, 0.5 mM phenylmethylsulfonyl
ﬂuoride (PMSF), 0.42 M NaCl and 1.5 mM MgCl2. The cells
were broken by vortexing (6· 20 s) in the presence of glass
beads (0.5 g), and 400 ml of the same buffer were added to the
suspension. After centrifugation at 19 000 g (14 000 r.p.m.) for
15 min at 4 C, the supernatant was used as crude protein
extract. Nuclear extracts were prepared by a method based
on that of (33) with the modiﬁcations indicated in (34).
Enzyme assays
For b-galactosidase activity determinations, crude extracts
were prepared with glass beads as described above and
o-nitrophenol-b-D-galactopyranoside (2 mg/ml) was used as
a substrate (27). Speciﬁc activity was calculated in relation to
total protein in the crude extract, using BSA as the standard.
Gel retardation assays
To investigate interaction of Rgt1 with the sequence carrying
the RGT1 element of HXK2 promoter we reconstituted the
fragment from two complementary oligonucleotides
(RGT1HXK2 sense, 50-tcgaGCAGTTTTTCCGGTCGAT-30;
RGT1HXK2 antisense, 50-tcgaATCGACCGGAAAAACTGC-
30). The complementary strands were annealed and either
end was labelled with [a-
32P]dCTP by ﬁll-in, using the Klenow
fragment of DNA polymerase I. The labelled double-stranded
DNA was used as probe and the unlabelled was used as com-
petitoringelretardationassays.Inallcasestheoligonucleotides
were synthesised with an added TCGA nucleotide overhang at
the 50-terminal end. Binding reactions contained 10 mM
HEPES (pH 7.5), 1 mM DTT, 1–5 mg of poly(dI–dC) and
0.5 ng of end-labelled DNA in a volume of 25 ml. When unla-
belled competitor DNA was added, its amount was 20 ng. The
binding reaction mixtures included 20 mg( 6ml) of the corres-
ponding nuclear extract and after 30 min of incubation at room
temperature they were loaded onto 4% non-denaturing polyac-
rylamidegels.Electrophoresis wascarriedoutat10V/cmofgel
for45minto1hin0.5· TBEbuffer(45mMTris–borate,1mM
EDTA). Gels were dried and autoradiographed at  70 Cw i t h
an intensifying screen.
Yeast two-hybrid analysis
The yeast two-hybrid analysis (35) employed yeast vectors
pGADT7, pACT2 and pGBDKT7 and host strains Y187,
Y187-Dsnf1 and Y187-Dtpk3 (described above) in accordance
with the Matchmaker two-hybrid system 3 from Clontech.
The transformed yeasts were grown in SD or SE/-Leu,Trp
medium. Assays for b-galactosidase activity followed
protocols described elsewhere (27). Qualitative assessment
of expression from the lacZ reporter gene was made using
X-gal as a chromogenic substrate for b-galactosidase in a
colony-lift ﬁlter assay. The b-galactosidase activity was
determined as indicated above. Expression levels of the
GAD and GBD fusion proteins were controlled by western
blot analysis. Experiments were performed a minimum of
three times. Values shown are representative results from
individual experiments.
Immunological methods
Immunoprecipitation experiments were performed by using
whole cell extracts, from a wild-type or hxk2D mutant yeast
strains transformed with the pWS93/RGT1 plasmid. Extracts
were incubated with anti-Hxk2 or anti-Pho4 for 1 h at 4 C.
Protein A–Sepharose beads (Amersham Biosciences) were
then added and incubated for 1 h at 4 C. After extensive
washes with Staph A buffer (150 mM NaCl, 100 mM
Na2HPO4, 18 mM NaH2PO4, pH 7.3, 20% Triton X-100,
1% SDS and 5% deoxycholate), immunoprecipitated samples
were boiled in SDS-loading buffer. The supernatant was
subjected to 12% SDS–PAGE and detected by western blot
using anti-HA antibody (Santa Cruz Biotechnology, Santa
Cruz., CA) and horseradish peroxidase (HRP)-conjugated
protein-A by the ECL system (Amersham Biosciences).
Western blot analysis was performed by using yeast-
transformed cells containing appropriate plasmids. We
found that it was important to rapidly denature proteins to
ensure that the Snf1 kinase was not activated by glucose
starvation during cell harvesting and protein extraction.
Mutants or wild-type yeast cells were grown on 10 ml of
high-glucose medium at 28 C until an optical density at
600 nm of 1.0. Cells were collected by centrifugation
(3000 g,4  C, 1 min), and crude extracts were prepared as
follows: yeasts were suspended in 100 ml of 250 mM Tris–
HCl (pH 6.8) buffer containing 8.0 mM EDTA, 2.5 mM b-
mercaptoethanol, 8.0% SDS and 35% glycerol. The cells were
broken by vortexing (6· 20 s) in the presence of glass beads
(0.5 g) and after adding 300 ml of phosphate-buffered saline
(PBS) buffer the suspension was boiled for 3 min. After centri-
fugation at 19 000 g (14 000 r.p.m.) for 15 min at 4 C, the
supernatant was used as crude protein extract. For western
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PAGE and transferred to enhanced chemiluminescence
nitrocellulose membrane (Amersham Biosciences) by electro-
blotting, which was then incubated with an anti-HA antibody
or with anti-Hxk2 polyclonal antibody. HRP-conjugated
protein A was used as secondary reactant. The complex
was detected by the ECL detection system (Amersham
Biosciences).
GST pull-down experiments
GST fusion protein expression vectors (pGEX-HXK2 and
pGEX-RGT1) were transformed into E.coli strain
BL21(DE3) pLysS. Cells were grown to A600 0.5–0.8, induced
with 0.5 mM isopropyl-1-thio-b-D-galactopyranoside at 37 C
for 3 h, and collected by centrifugation. Cell pellets were
resuspended in PBS buffer (150 mM NaCl, 100 mM
Na2HPO4 and 18 mM NaH2PO4, pH 7.3) and sonicated.
Insoluble material was removed by centrifugation (17 000 g
for 20 min at 4 C). Soluble extracts were incubated with
glutathione–Sepharose 4B (Amersham Biosciences) for 1 h
at 4 C, washed extensively with PBS buffer and resuspended
in the same buffer. The GST-Hxk2 fusion protein coupled to
glutathione–Sepharose beads was incubated with 2.5 U of
thrombin (2 h at 4 C) for site-speciﬁc separation of the
GST afﬁnity tag from Hxk2 protein. Approximately, equal
amounts of GST-Rgt1 coupled to glutathione–Sepharose
beads were incubated with Hxk2 puriﬁed protein or yeast
whole cell extracts from pWS93/MED8 transformed wild-
type yeast strain, for 1 h at 4 C in PBS buffer. Beads were
gently washed ﬁve times with 2.5 ml of PBS buffer, boiled in
25 ml sample-loading buffer (50 mM Tris–HCl, pH 6.8,
100 mM DTT, 2% SDS, 0.1% bromophenol blue and 10%
glycerol), and analysed by SDS–PAGE followed by western
blot using anti-HA antibodies and HRP-conjugated protein
A. Bound antibodies were detected using the ECL system
(Amersham Pharmacia Biotech).
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assays were per-
formed essentially as described previously (36,37) with the
following modiﬁcations. A 50 ml culture of yeast (OD600 ¼ 1)
was treated with formaldehyde (ﬁnal concentration 1%) for
60 min at 20 C, and 2.5 ml of 2.5 M glycine was added to stop
the cross-linking reaction. Cells were harvested and disrupted
by vortexing in the presence of glass beads, and the lysate was
sonicated to generate DNA fragments that ranged in size from
200 to 400 bp. To immunoprecipitate HA-tagged proteins,
we incubated anti-HA antibody (Santa Cruz Biotechnology,
Santa Cruz, CA) with the extract overnight at 4 C, and the
extract-antibody mixture then was incubated for an additional
3–4hwithproteinA–Sepharosebeads(AmershamBiosciences).
Immunoprecipitates were washed 4-fold with 1 ml each of
lysis buffer (50 mM HEPES, pH 7.5, 250 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 1 mM
PMSF, 1 mg/ml leupeptine and 1 mg/ml pepstatin A). The DNA
was eluted with elution buffer (100 mM sodium bicarbonate
and 1% SDS). After reversal of the formaldehyde-induced
cross-links, 1/5000 of input DNA and 1/45 of each immuno-
precipitated DNA were used as templates for ampliﬁcation by
PCR.ThesequencesofprimersforPCRwereasfollows:forthe
HXK2 promoter region containing the RGT1 element, OL7, 50-
ACTACGAGTTTTCTGAACCTCC-30 and OL8, 50-TAAT-
TTCGTGGATCTCGAATC-30 and for the HXK2 gene region
containing the MED8 element, OL9, 50-GGAATTGATGCAA-
CAAATTGAG-30;a n dO L 1 0 ,5 0-GATTGAGTGGTGTCAA-
AGGTAC-30.
RESULTS
Glucose-regulated phosphorylation of Rgt1 in vivo
Previous results have indicated that in cells grown in low
glucose, Rgt1 is dephosphorylated and binds to several
HXTs regulatory promoter regions. Conversely, high
glucose-induced phosphorylation of Rgt1 inhibits its DNA-
binding activity (10,11). To determine whether the binding
of Rgt1 to the RGT1 regulatory element within the HXK2
promoter entails dephosphorylation of Rgt1, we examined
the phosphorylation state of Rgt1 in vivo during growth in
high and low glucose (Figure 1). For this purpose, we prepared
extracts from mutant rgt1D transformed cells with the HA-
Rgt1 construct grown in the presence of high or low glucose.
The extracts were analysed by western blot using a
monoclonal HA antibody. As shown in Figure 1A (lane 1),
Rgt1 from high-glucose grown cells display a slight shift in
Figure 1. Rgt1 phosphorylation in response to glucose availability. (A) Cells,
from an rgt1D mutant strain transformed with the HA-Rgt1 construct, were
growninhigh-glucose(H-Glc)orlow-glucose(L-Glc)mediauntilanOD600of
1.0. Cell extracts were treated with or without l-phosphatase for 30 min in the
presence,orintheabsenceofphosphataseinhibitors.Rgt1proteinwasdetected
from total cell extracts by SDS–PAGE followed by immunoblotting with anti-
HA antibody. (B) The mutant rgt1D strain transformed with the HA-Rgt1
construct was grown in the presence of low-glucose until an OD600 of 1.0
and transferred to medium with high glucose for 30 min. Finally cells were
transferred to a medium with low glucose for 60 min. Rgt1 was detected and
identified as described in (A). The phosphorylated forms of Rgt1 are indicated
as hP (hyperphosphorylated), P (phosphorylated) and dP (dephosphorylated).
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grown cells (Figure 1A, lane 4). To conﬁrm that this decreased
mobility is due to phosphorylation, we treated protein extracts
from high-glucose grown cells expressing HA-Rgt1 with
l-phosphatase in the presence or absence of phosphatase
inhibitors. The modiﬁed form of Rgt1 disappeared after treat-
ment with l-phosphatase but remained in the presence of
phosphatase inhibitors. This indicated that the modiﬁcation
was due to phosphorylation (Figure 1A, lanes 2 and 3). Inter-
estingly, Rgt1 in extracts from cells grown in the presence of
low-glucose was also sensitive to l-phosphatase, indicating
that Rgt1 is also phosphorylated in low glucose (Figure 1A,
lanes 5 and 6). Thus, the Rgt1 appeared to exist in three
different phosphorylation states as resolved by its SDS–
PAGE mobility: (i) a hyperphosphorylated state during growth
in high glucose, (ii) an additional phosphorylated state during
growth in low glucose medium, and (iii) a dephosphorylated
state when the protein extracts were treated with l-
phosphatase.
Rgt1 hyperphosphorylation occurred rapidly (30 min) when
the cells were shifted from low to high glucose medium
(Figure 1B, lanes 2 and 5). Furthermore, this hyper-
phosphorylation was reversible when cells were reintroduced
into low glucose media. During this event, the modiﬁed hyper-
phosphorylated form of Rgt1 rapidly disappeared (Figure 1B,
lanes 6 and 7).
These results indicated that Rgt1 undergoes hyper-
phosphorylation in response to high-glucose in accordance
with previous results (10). Our results also indicated that
the basal phosphorylation state of Rgt1 is present in cells
grown in low-glucose medium. The dephosphorylated state
of Rgt1 was only detected after l-phosphatase treatment of
cell extracts and is likely not of signiﬁcant physiological
relevance.
Tpk3 and Snf1 protein kinases regulate the Rgt1
phosphorylation state
In cells grown in high glucose, PKA and Rgt1 proteins are
localized to the nucleus (17,18) and PKA activity is stimulated
by extracellular glucose. Thus, PKA is an intriguing candidate
kinase that can directly hyperphosphorylate Rgt1. To
determine whether PKA is responsible for Rgt1 modiﬁcation,
we used the double-disruption mutant strains of tpk1 tpk2
(tpk12); tpk1 tpk3 (tpk13) and tpk2 tpk3 (tpk23), each lacking
two of the three possible catalytic subunits of PKA. The
utilization of these double-mutant strains avoids redundant
functions of the catalytic subunits of PKA. Rgt1 hyperphos-
phorylation was detected in tpk12 cells grown in high-glucose
medium (Figure 2A, lane 3), but it did not take place in the
tpk13 and tpk23 mutants (Figure 2A, lanes 4 and 5). This
suggests that PKA complexes containing the Tpk3 subunit
is directly or indirectly responsible for this Rgt1 modiﬁcation
(Figure 2A). To further conﬁrm that the Tpk3 catalytic subunit
of PKA is involved in Rgt1 hyperphosphorylation, we also
used a tpk3D single-mutant strain. Rgt1 hyperphosphorylation
was not detected in tpk3D mutant cells grown in high-glucose
medium(Figure2A,lane 9)indicatingthatTpk3 isresponsible
for Rgt1 hyperphosphorylation.
Interestingly, the observed phosphorylation of Rgt1 under
conditions of low-glucose growth was abolished in the snf1
mutant strain (Figure 2B, lane 4). Furthermore, this phos-
phorylation was induced in reg1 mutants lacking the
regulatory subunit of the Reg1-Glc7 protein phosphatase
complex under conditions of high glucose (Figure 2C,
lane 3). Since the Snf1 protein kinase is highly active in
reg1 mutant cells during high-glucose growth, this suggests
an essential role of Snf1 in the phosphorylation of Rgt1 under
conditions of glucose limitation. Taken together, these results
suggest that Rgt1 phosphorylation, in response to glucose
limitation, is dependent on Snf1 protein kinase activity, and
Rgt1 hyperphosphorylation, in response to high-glucose
levels, is Tpk3-dependent.
Snf1-dependentphosphorylationofRgt1promotesDNA
binding to the HXK2 promoter and Tpk3-dependent
hyperphosphorylation of Rgt1 promotes DNA release
from the HXK2 promoter
Previous reports have demonstrated that Rgt1 binds to the
RGT1-binding site in the HXK2 promoter during low-
glucose conditions (7). As shown above, in low glucose
Figure 2. Tpk3 and Snf1 protein kinases are involved in in vivo Rgt1 phos-
phorylation. Cells from an rgtD mutant strain transformed with the HA-Rgt1
construct, were grown in high-glucose (H-Glc) medium until an OD600 of 1.0,
and transferred to medium with low-glucose (L-Glc) for 60 min. HA-Rgt1
levels as well as electrophoretic mobility, were monitored in wild-type
(W303-1A), tpk12D,tpk13D, tpk23D and tpk3D (A), snf1D (B) and reg1D
(C) cells. The positions of hyperphosphorylated (hP), phosphorylated (P)
and dephosphorylated (dP) Rgt1 are shown next to the immunoblots.
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by an Snf1-dependent kinase. Consequently, we investigated
whether the phosphorylation state of Rgt1 determines the abil-
ity of this protein to bind to its target in the HXK2 promoter
both in vivo and in vitro. To test this hypothesis, we used ChIP
and gel electrophoretic mobility shift assays (EMSAs). Our
results showed that in cells grown in low glucose medium,
Rgt1 was recruited to the HXK2 promoter in the three tpk
mutant strains (Figure 3A, a, lanes 2–4). Conversely, in
high glucose medium, Rgt1 binding to the HXK2 promoter
was abolished in the tpk12 mutant, but not in tpk13 and tpk23
mutant cells (Figure 3A, b, lanes 2-4). From these results, we
propose that Tpk3 protein kinase activity is necessary for in
vivo Rgt1 release from the HXK2 promoter. In the snf1 mutant
strain, Rgt1 was recruited to the HXK2 promoter in the
presence of high glucose, but no binding to the HXK2
promoter was detected in low-glucose medium (Figure 3A,
b and a, lane 5). This result suggests a direct correlation
between in vivo Snf1-dependent phosphorylation of Rgt1,
and its binding activity to the HXK2 promoter (Figure 3A,
a, lane 5). The binding of Rgt1 to the HXK2 promoter in snf1
mutant cells grown in the presence of high glucose (Figure 3A,
b, lane 5) is not completely understood. One possible explana-
tion could be that partial Rgt1 phosphorylation by an unknown
protein kinase (Figure 2B, lane 2) could allow Rgt1 binding to
the HXK2 promoter during high-glucose growth. No DNA
ampliﬁcation was observed when we used cells with untagged
Rgt1. This result demonstrates that the observed signals are
dependent on the HA-tagged protein.
Next, we determined whether the presence or absence of
Snf1 and Tpk3 proteins could induce differential band shifting
with nuclear extracts prepared from wild-type and snf1D,
tpk12D and tpk23D mutant strains. To accomplish this, we
used the RGT1 element of the HXK2 promoter in EMSAs.
As shown in Figure 3B, we observed a retarded DNA–protein
complex (CI) with nuclear extracts from wild-type cells grown
in low-glucose medium, but not in high-glucose grown cells
(Figure 3B, lanes 8 and 9). The CI complex was also detected
by using nuclear extracts from both tpk mutant cells grown in
low-glucose medium, and nuclear extracts from tpk23 mutant
cells grown in high-glucose medium (Figure 3B, lanes 5–7).
However, the CI complex was not formed with extracts from
snf1D mutant cells grown in low-glucose medium, or the tpk12
mutant cells grown in high-glucose medium (Figure 3B,
lanes 3 and 4). The speciﬁcity of this binding was demon-
strated by competition assays with non-labelled oligo-
nucleotides (data not shown). Together, these results
suggest the involvement of Snf1 protein kinase in the control
of Rgt1-binding activity to the HXK2 promoter. The Tpk3
protein kinase activity is also necessary for Rgt1 release
from the HXK2 promoter in cells grown in the presence of
high-glucose.
Snf1 protein kinase regulates HXK2 gene expression
To gain more insight into the relationship between the Rgt1
phosphorylation state, its DNA-binding activity, and HXK2
gene expression, we used snf1D and tpk3D mutant strains
transformed with a single copy of the yeast reporter plasmid
YIp357/HXK2+404 (29) integrated at the URA3 locus. Since
the HXK2 promoter drives glucose-regulated expression of the
reporter gene, we measured b-galactosidase activity in the
presence of high and low levels of glucose. We found that,
in low glucose-grown cells, lacZ expression increased 12-fold
in snf1 mutant cells with respect to the basal level detected in
wild-type cells grown in low-glucose medium. The deletion of
the TPK3 gene did not affect b-galactosidase activity.
Conversely, in high glucose-grown cells, SNF1 and TPK3
gene deletions did not affect expression of the reporter gene
(Figure 4). Thus, from these experiments, a clear relationship
between Snf1-dependent phosphorylation state of Rgt1 and
HXK2 gene expression can be deduced. Surprisingly, the
absence of Tpk3 protein did not induce HXK2 gene repression




tpk23 and snf1 mutant strains, transformed with the HA-Rgt1 construct, were
grown in high-glucose (H-Glc) medium (b) until an OD600 of 1.0 and then
transferred to medium with low-glucose (L-Glc) for 60 min (a). The W303-1A
wild-typestrainwasalsotransformedwithanemptypWS93plasmidtobeused
as a control with untagged Rgt1 (lane 6). The cells were treated with formal-
dehydetocross-linkproteinsboundtoDNA.ChIPwasperformedwithanti-HA
antibody. Input and immunoprecipitated DNA was amplified by PCR using
primer pairs spanning the RGT1 element of the HXK2 gene promoter. PCR
productswereresolvedona2%agarosegelandvisualizedbyethidiumbromide
staining. (B) EMSA was performed with probe RGT1HXK2 by using nuclear
extracts derived from exponentially growing wild-type cells, and snf1, tpk1-2
and tpk2-3 mutant cells as indicated above the lanes. Lanes 1 and 10 are probe
alone controls. CI, marks the position of the Rgt1-dependent shifted complex.
F, free DNA.
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glucose-dependent manner
As we have demonstrated previously, Rgt1 and Med8 form
part of a DNA–protein complex that interacts with the RGT1
and DRS regulatory elements of the HXK2 gene promoter,
respectively. Although, Rgt1 only binds to DNA in a
glucose-dependent manner, both Med8 and Rgt1 functions
are required to repress HXK2 expression in low-glucose
medium (7). However, a direct or indirect interaction between
Rgt1 and Med8 proteins has not yet been demonstrated.
Furthermore, Hxk2 is involved in a positive feedback loop
that serves to amplify its own expression (25), and in the
presence of high-glucose, the Med8 protein interacts with
Hxk2 (9). Thus, it was plausible to postulate that Hxk2
could be directly or indirectly involved in the control of
Rgt1 repression of the HXK2 gene. To test this hypothesis,
we examined potential interactions of Rgt1 with Med8 and
Hxk2 by yeast two-hybrid assays. The pGBKT7/RGT1
plasmid (Materials and Methods) was introduced together
with a plasmid expressing a fusion of the Gal4 activation
domain with Med8, or one with Hxk2 into an appropriate
reporter strain. The interaction was monitored in low- and
high-glucose conditions by determining b-galactosidase
expression levels.
As shown in Figure 5B, full-length Rgt1 did not interact
with Med8 in the presence of high glucose. However, a strong
interaction occurred within 5 min after shifting the cells from
medium containing high glucose to low glucose. On the other
hand, full-length Rgt1 interacts with Hxk2 in the presence
of high glucose, but does not interact at low glucose
concentrations.
To identify the domains of Hxk2 that are important for
interaction with Rgt1, sub-fragments of Hxk2 were similarly
tested for its interaction with Rgt1. As shown in Figure 5B,
Hxk2-416, Hxk2-136 and Hxk2-87 proteins were not able to
interact with full-length Rgt1 in the presence of high glucose.
These results indicate that the interacting domain of Hxk2
might include a motif in its C-terminal region that is essential
in this function. An alternative possibility is that the deletions
introduced a structural modiﬁcation, preventing the interac-
tion, despite the presence of the interacting motif. The lack of
interaction cannot be attributed to lack of expression, as the
GAD-Hxk2-416, Hxk2-136 and Hxk2-87 fusion proteins were
detected by western blotting using anti-Hxk2 antibody (data
not shown).
Figure 4. InfluenceofSnf1andTpk3proteinkinaseactivitiesontheregulation
of HXK2 gene expression. HXK2 expression was measured by using the lacZ
expression reporter gene. One copy of the HXK2+404::lacZ construct, contain-
ing the downstream Med8 binding and the upstream Rgt1-binding regulatory
elements, was integrated into the chromosome at the URA3 locus of the wild-
type strain W303-1A, creating the FMY152 strain. The FMY152-t3 and
FMY152-s1 strains were obtained by transformation of the FMY152 strain
with a tpk3::kanMX4 or snf1::kanMX4 alleles, respectively. b-Galactosidase
activities are the averages of results obtained from four to five independent
experiments. Average values have SEs of 10% or less. Yeasts cultures
were grown in high-glucose medium (open bars) until an OD600 of 1.0 and
then transferred to medium with low-glucose (closed bars) for 60 min.
b-Galactosidase activity was assayed in crude extracts.
Figure 5. Interaction of Rgt1 with Hxk2 and Med8. (A) Schematic representa-
tion of the constructs employed. Hxk2 BD, Hxk2-binding domain; Mig1 BD,
Mig1-binding domain; Glc-BD, glucose-binding domains; Med8 BD,
Med8-binding domain. (B) Yeast two-hybrid assay of Med8 and Hxk2
interaction with Rgt1 protein (closed bars) and with GBD alone (open bars).
Truncated (Hxk2–416, amino acids 1–416; Hxk2–136, amino acids 1–136 and
Hxk2–87, amino acids 1–87) and full-length (Hxk2, amino acids 1–485)
versions of Hxk2 fused to the Gal4 activation domain (GAD) were
co-transformed into yeast strain Y187 with constructs encoding the Gal4-
binding domain alone (GBD) or GBD fused to full-length (Rgt1, amino acids
1–1170)Rgt1.Full-lengthRgt1fusedtotheGal4DNAbindingdomain(GBD)
wasalso co-transformedinto yeast strainY187 withthe constructencodingthe
Gal4 activation domain alone (GAD), as indicated in (C) (dashed bar).
The transformed yeast cells were grown in SD (high-glucose; H-Glc) or SE
(low-glucose; L-Glc) media with selection for plasmid maintenance. Protein–
protein interactions were examined in each transformant by the qualitative and
quantitative assay methods for b-galactosidase activity. Strains from bars
marked with asterisk gave a blue colony colour in the qualitative assay. The
valuesaretheaveragesofb-galactosidaseactivityforthreetransformants.Each
measured value was within 12% of the average.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1433The interaction between Rgt1 and Hxk2 was conﬁrmed
by immunoprecipitation assays in cells expressing HA-Rgt1
and Hxk2. Cell extracts were immunoprecipitated with
the antibodies indicated in Figure 6A. The resulting
immunoprecipitates were assayed for the presence of Rgt1
by immunoblot analysis with anti-HA antibodies. As shown
in Figure 6A, a signal for Rgt1 was observed only with
samples immunoprecipitated with an anti-Hxk2 antibody
(lane 3). In control reactions, no signals were obtained
when the experiment was done without any antibodies,
the anti-Pho4 antibody, or extracts from the hxk2D
mutant strain (lanes 1, 2 and 4). Thus, this interaction is
dependent on the production of HA-tagged Rgt1 and Hxk2.
Since some unknown proteins in the extract could mediate
the interaction between Hxk2 and Rgt1, we tested for the
direct interaction between Rgt1 with Hxk2 using pull-down
assays. We used puriﬁed Hxk2 protein and a bacterially
produced GST-Rgt1 fusion protein. As shown in Figure 6B
(lane 2), strong and speciﬁc retention was detected with the
sample containing the puriﬁed GST-Rgt1 fusion protein.
No signal was detected when puriﬁed GST was used in the
experiment (lane 3). To conﬁrm the Rgt1–Med8 interaction,
we performed GST pull-down experiments with crude protein
extracts and a puriﬁed GST-Rgt1 fusion protein. The extracts
were obtained from yeast cells grown in SE (low-glucose)
media with selection for plasmid maintenance. As shown
in Figure 6C, a clear retention of Med8 protein was observed
for the samples containing GST-Rgt1, and in crude
extracts from the wild-type yeast strain W303-1A expressing
a Med8 HA-tagged protein (lane 3). When a control with GST
protein in the reaction mixture was used, no signal was
observed (lane 2).
Snf1 protein kinase modulates Rgt1 interaction with
Med8 and Hxk2
Our yeast two-hybrid data indicated that Rgt1 interacts with
Med8 and Hxk2 in a glucose-dependent manner. This obser-
vation and the data presented above prompted us to investigate
by yeast two-hybrid assays whether Snf1 and Tpk3-dependent
phosphorylation of Rgt1 affects its interaction with Med8
and Hxk2.
As indicated in Figure 7A, in Dsnf1 mutant cells, full-length
Rgt1 does not interact with Med8 and Hxk2 in the presence of
high or low-glucose. Because the dephosphorylated form of
Rgt1 was detected in the Dsnf1 cells grown in low-glucose
medium (Figure 2B), its failure to interact with Med8 could be
a consequence of the different phosphorylation states the two
proteins. This suggests that Rgt1 interaction with Hxk2 may
require its Snf1-dependent phosphorylation.
As shown in Figure 7B, in Dtpk3 mutant cells, full-length
Rgt1 does not interact with Med8 in the presence of high
glucose. However, a strong interaction occurred within
5 min after shifting the cells from medium containing high
glucose to low glucose medium. On the other hand, full-length
Rgt1 interacted with Hxk2 in the presence of high glucose,
but did not interact in low glucose concentration. As shown
above, identical results were obtained with the wild-type
strain (Figure 5B). Our data suggest that Rgt1 interaction
with Med8 and Hxk2 does not require its Tpk3-dependent
phosphorylation.
Rgt1andMed8formsloopsintheHXK2generegulatory
region via protein–protein interactions
Once we identiﬁed the in vivo and in vitro interaction of Rgt1
with Med8, and demonstrated that Snf1-dependent phos-
phorylation of Rgt1 regulates the binding activity between
both proteins, a logical question to ask was whether in vivo
Figure 6. ImmunoprecipitationandGSTpull-downassaysoftheinteractionof
Rgt1 with Hxk2 and Med8. (A) In vivo co-immunoprecipitation of Rgt1 with
Hxk2. S.cerevisiae Y187 and the mutant strain hxk2D were transformed with
HA-tagged Rgt1 protein. Cell extracts from the transformed Y187 wild-type
strain grown in SD (high-glucose) medium, with selection for plasmid main-
tenance (lane 1), were immunoprecipitated with a polyclonal antibody to Pho4
(lane 2), or a polyclonal antibody to Hxk2 (lane 3). Cell extracts from the
transformed hxk2D cells grown in SD (high-glucose) medium, with selection
forplasmidmaintenance,wereimmunoprecipitatedwithapolyclonalantibody
to Hxk2 (lane 4). Immunoprecipitates were separated by 10% SDS–PAGE and
co-precipitated HA-Rgt1 was visualized on a western blot with an anti-HA
antibody. (B) GST pull-down assays of the interaction between Rgt1-Hxk2.
Purified Rgt1 interacts with purified Hxk2. A GST-Hxk2 fusion protein was
purified on glutathione–Sepharose columns and incubated with thrombin to
isolate native Hxk2 (lane 1). Hxk2 was incubated with purified GST-Rgt1 or
with GST on glutathione beads and washed extensively. Co-precipitated
proteins were resolved on 10% SDS–PAGE. The Hxk2 protein was visualized
on a western blot with anti-Hxk2 antibody. (C) Med8 protein co-precipitates
together with Rgt1 from cell extracts. Extract from the yeast strain W303-1A
(transformed with the plasmid pWS93/MED8), expressing the Med8-HA
fusionprotein,wasincubatedwithGST-Rgt1orwithGSTpurifiedfromE.coli




1434 Nucleic Acids Research, 2006, Vol. 34, No. 5binding of Rgt1 and Med8 affects DNA secondary structure.
This may include modiﬁcations such as looping, which could
bring the Rgt1 and Med8 distal-binding sites into close prox-
imity. To address this issue, we used a formaldehyde
crosslinking-immunoprecipitation assay (ChIP) with cells
grown in low-glucose containing medium.
The results indicate that our chromatin sonication protocol
breaks the DNA between the Med8 and Rgt1-binding sites,
because no ampliﬁcation was detected by using primer pair
7+10 for PCR (Figure 8B, lane 6). Interestingly, signiﬁcant
levels of the upstream HXK2 regulatory region containing the
Rgt1-binding site were found when DNA–protein complexes
were immunoprecipitated with the anti-Med8 antibody
(Figure 8B, lane 7). Furthermore, signiﬁcant levels of the
downstream HXK2 regulatory region containing the Med8-
binding site were found when DNA–protein complexes
were immunoprecipitated with an anti-Rgt1 antibody
(Figure 8B, lane 8). This co-immunoprecipitation of the
DNA containing the MED8 element with anti-Rgt1 antibody,
and the DNA containing the RGT1 element with anti-Med8
antibody, can only be explained if Rgt1 and Med8 proteins
interact during the formaldehyde crosslinking step of the ChIP
experiment.
However, no ampliﬁcation was detected by using primer
pair 7+10 for PCR in both anti-Med8 and anti-Rgt1 antibody
for immunoprecipitations (Figure 8B, lane 9). Neither was a
signal detected, when we used protein extracts from cells with
untagged Rgt1 or Med8 proteins (Figure 8B, lanes 10 and 11).
This control experiment suggests that the observed signals
are HA-Rgt1 or HA-Med8 dependent.
DISCUSSION
These studies were undertaken to address the mechanisms of
transcriptional control of the HXK2 gene. Hxk2 is the protein
that initiates the intracellular metabolism of glucose by
phosphorylation at C6, but Hxk2 also plays a vital role in
glucose repression (4). A cellular fraction of this protein
has a glucose-regulated nuclear localization and operates
by interacting with Mig1 to generate a repressor complex in
the nucleus of S.cerevisiae during growth in glucose (5).
Similarly, recent studies in mammalian hepatic cells suggest
that glucokinase (GK), the type IV isoenzyme of hexokinase
(HKIV), has the capacity to enter the nucleus where it is
essential to control the activity of transcriptional factors
like ChREBP and SREBP (38). All these factors participate,
by direct binding to DNA, and regulate the transcription of
several genes involved in glucose metabolism and lipogenesis
(39). An increasing amount of biochemical and genetic
evidence points to the possibility that Hxk2 and HKIV
could function through similar mechanisms in glucose signal-
ling (40). Thus, experiments to elucidate the transcriptional
control of the HXK2 gene are of maximal signiﬁcance.
In this paper, we present a molecular analysis of Rgt1, a
transcriptional regulator which together with the Med8
protein, regulates the HXK2 gene expression in a glucose
dependent manner (7). The correlation between the Rgt1
phosphorylation state, DNA-binding activity to the HXT1
cis-actingelements,andHXT1genetranscriptioniswellestab-
lished (10,11,37,41). However, the impact of Rgt1 on the
HXK2 transcription has never been assessed properly. Here,
we show through western analyses in different media and by
using several null-mutant strains that Snf1 and Tpk3 protein
kinases couple glucose levels to Rgt1 phosphorylation state.
This affects the DNA-binding activity of Rgt1 and regulates
the transcription of the HXK2 gene through its protein–protein
interacting activity. The results presented here suggest that the
Snf1 protein kinase is involved directly or indirectly in the
Figure 7. Interaction of Rgt1 with Hxk2 and Med8 in the absence of Snf1 and
Tpk3 protein kinases. Yeast two-hybrid assay of Med8 and Hxk2 interaction
with Rgt1 protein (solid bars) in the Dsnf1 (A) and Dtpk3 (B) mutant strains.
Control experiments with GBD alone (open bars) were also performed. The
full-length Rgt1 fused to the Gal4 DNA-binding domain (GBD) was co-
transformed into yeast strains Y187-Dsnf1 and Y187-Dtpk3 with the construct
encoding the Gal4 activation domain alone (GAD) (dashed bar). The trans-
formedyeastcellsweregrowninSD(high-glucose;H-Glc)orSE(low-glucose;
L-Glc) media with selection for plasmid maintenance. Protein–protein inter-
actions were examined in each transformant as indicated in the legend of
Figure 5.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1435activation function of Rgt1 as a repressor. Deletion of the
SNF1 gene results in a dephosphorylated Rgt1 protein with
neither DNA-binding activity nor HXK2 repression in low-
glucose medium. Moreover, in reg1 mutants lacking the
regulatory subunit of the Reg1–Glc7 protein phosphatase
complex and possessing constitutive Snf1 protein kinase
activity Rgt1 phosphorylation is induced during glucose
growth. These observations reafﬁrm previous observations
on the regulation of HXTs genes (10,11,41) and implicate
the Rgt1 mechanism to HXK2 transcriptional regulation.
Our results also suggest that the Tpk3 catalytic subunit of
cAMP-dependent protein kinase is essential for Rgt1 release
from the HXK2 promoter. Deletion of the TPK3 gene results in
a loss of hyperphosphorylated Rgt1 and an increase of DNA
binding activity in the presence of high-glucose.
HXK2transcriptionalrepressionisdependenton thebinding
of Rgt1 and Med8 to their target DNA elements within the
HXK2 promoter (7). Interestingly, the data presented here
suggests that an interaction between Rgt1 and Med8 is also
essential for the repression of Rgt1 function. This idea is
supported by the following ﬁndings: (i) deletion of SNF1
gene prevents Rgt1 binding to the HXK2 promoter in yeast
cells growing in low-glucose medium and activates HXK2
gene expression, (ii) deletion of SNF1 gene prevents
Rgt1 interaction with Med8 in low-glucose growing cells,
(iii) deletion of the TPK3 gene prevents Rgt1 release from
the HXK2 promoter in yeast cells growing in high-glucose
medium, but does not affect HXK2 gene expression,
(iv) Rgt1 does not interact with Med8 in the presence of
high-glucose, and (v) proper HXK2 repression only occurs
Figure 8. Med8 and Rgt1 proteins interact at the HXK2 promoter level. (A) Model showing the three DNA fragments that were analysed: the downstream HXK2
regulatoryregioncontainingtheMed8-bindingsite(266bp),theupstreamHXK2regulatoryregionwhichcontainstheRgt1bindingsite(286bp),andasacontrol,a
region of 854 bp which contains both Med8 and Rgt1-binding sites. (B) Wild-type cells expressing HA-tagged Rgt1 or HA-tagged Med8 proteins (a) and untagged
Rgt1 or Med8 proteins (b) were grown in low-glucose medium untilan OD600 of 1.0, lysed and subjected to ChIP.Genomic DNA wasused as positivePCR control
(lanes1–3).Crosslinked-sonicatedDNA(lanes4–6)andimmunoprecipitatedDNA(lanes7–11)wereamplifiedbyPCRusingprimerpairsspanningtheRGT1(7+8)
and MED8 (9+10) elements of the HXK2 gene. These primer pairs had been defined previously to characterize Rgt1 and Med8 DNA binding. Wild-type cells
expressinguntaggedRgt1orMed8proteinswereusedintheChIPexperimentasnegativecontrols(lanes10and11).PCRproductswereresolvedona2%agarosegel
and visualized by ethidium bromide staining.
1436 Nucleic Acids Research, 2006, Vol. 34, No. 5in low-glucose, whenRgt1 isbound to the HXK2 promoter and
the interaction between Rgt1 and Med8 takes place.
Our results also demonstrate that Rgt1 interacts directly
with Hxk2 and Med8 in a glucose-dependent manner, and
that the C-terminal domain of the Hxk2 protein is required
forthe Hxk2–Rgt1interaction.Since the C-terminaldomainof
the Hxk2 protein is also necessary for Med8 interaction in the
presence of high glucose (9), a possible competition between
the Med8 and Rgt1 proteins for Hxk2 binding could be estab-
lished during growth on high glucose. However, an alternative
possibility is that the Hxk2 C-terminal deletions have intro-
duced structural modiﬁcations, preventing the interaction
between Hxk2 and Rgt1 proteins despite the presence of
the interacting motif.
Thedatapresentedaboveraises theissueabouttheinﬂuence
of Snf1 and Tpk3-dependent phosphorylation of Rgt1 in
its interaction with Med8 and Hxk2. Our results show
that regulation of Rgt1 interaction with Med8 through
Snf1-mediated phosphorylation is a key molecular switch
that controls HXK2 repression. In cells grown in low glucose,
the RGT1 element of the HXK2 promoter is occupied by the
phosphorylated Rgt1, which interacts with Med8. This Rgt1
phosphorylation is important both for DNA and protein inter-
action. Under high-glucose conditions, Rgt1 is hyperphos-
phorylated in a Tpk3-dependent manner. Thus, Tpk3-
mediated hyperphosphorylation of Rgt1 is a prerequisite for
DNA release, but is not necessary to induce Rgt1 interaction
with Hxk2.
A simpliﬁed diagram of how nutritional signals converge on
Rgt1 through the Snf1 and Tpk3 protein kinases, according to
our results, is presented in Figure 9. The glucose-regulated
interaction of Rgt1 with Med8 and Hxk2 was proposed. This
creates speciﬁc structures at the HXK2 promoter that would
accommodate differences in the spacing of regulatory DNA
elements and inﬂuence chromatin structure. Chromatin
looping as a result of remote sequences being brought close
together might be involved in gene activation or repression by
the binding of components of the basal transcription
machinery. This would facilitate or make difﬁcult the
formation of active transcriptional complexes (42). In fact,
chromatin looping was detected recently in mammalian loci
for b-globin (43), the Igf2 (44) and Dlx5 (45). Our results
suggest that HXK2 regulation results from the formation
of a loop in the DNA that includes the promoter and the
coding region of the HXK2 gene between the Rgt1 and
Med8 binding sites.
The interaction between Rgt1 and Med8 provides a new
mechanism for modulating the transcriptional response of the
HXK2 promoter to low glucose. We propose that this
mechanism acts in concert with Snf1 or an Snf1-dependent
protein kinase to initiate Rgt1 binding to the HXK2 promoter
in low glucose. Conversely, the Tpk3 catalytic subunit of PKA
initiates Rgt1 release from the HXK2 promoter in high-glucose
conditions.
These results suggest that HXK2 transcription is repressed
by the state of the chromatin over the promoter. The chromatin
barrier over the HXK2 promoter could be released by binding
the hyperphosphorylated Rgt1 to the Hxk2 nuclear protein.
This Rgt1 sequestering results in the observed activation of
the HXK2 expression, as it would make the promoter access-
ible to the RNA II polymerase complex, as well as to other
mediator factors. Thus, our model also explains how Hxk2 is
involved in a positive-feedback loop that serves to amplify its
own expression (25).
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Figure 9. A model explaining the mechanism by which Snf1 and Tpk3 protein
kinases regulate HXK2 transcription. In low-glucose conditions (L-Glc(), Rgt1
isphosphorylatedbySnf1oranSnf1-dependentproteinkinase.Thephosphory-
lated Rgt1 binds to the RGT1 element of HXK2 promoter to repress HXK2
transcription by looping DNA and bringing the Rgt1 and Med8 distal binding
sites into close proximity. In high-glucose conditions (H-Glc(), Rgt1 is hyper-
phosphorylatedbyTpk3.Thehyperphosphorylatedformissequesteredoutside
its DNA-binding site by interacting with the nuclear Hxk2 protein, resulting in
expression of the HXK2 gene. An arrow denotes positive expression. An arrow
marked with double bars denotes negative expression. Positive regulation is
marked by plus.
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